Related Experiment Videos
Prospects for treatment of free radical-mediated tissue injury
1Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Abstract:
Toxic metabolites of oxygen are generated normally by aerobic metabolism in cells and this generation can significantly increase in certain pathologic conditions. When endogenous antioxidant defense capabilities are exceeded by this oxidant flux, tissue injury occurs. This process can be intercepted pharmacologically at different levels with agents that scavenge reactive oxygen metabolites, block their generation, or enhance endogenous antioxidant capabilities. In many situations, such as the treatment of post-ischaemic reperfusion injury, efficacy of antioxidant is related primarily to the proportionate magnitude of the total injury sustained that is due to an antioxidant mechanism. This approach has shown great promise in animal models of clinical problems and has been tested successfully in early, controlled clinical trials.
Insights
Antioxidant therapies can combat tissue injury caused by excess oxygen metabolites during aerobic metabolism. These treatments show promise in animal models and early human trials for conditions like reperfusion injury.
Area of Science:
- Biochemistry
- Cellular Biology
- Pharmacology
Background:
- Aerobic metabolism normally produces toxic oxygen metabolites.
- Pathologic conditions can increase oxidant production, overwhelming antioxidant defenses.
- This imbalance leads to cellular and tissue injury.
Purpose of the Study:
- To explore the role of antioxidants in mitigating tissue injury.
- To investigate pharmacological interception of oxidant-induced damage.
- To evaluate the efficacy of antioxidant strategies in clinical settings.
Main Methods:
- Pharmacological agents designed to scavenge reactive oxygen species.
- Inhibitors targeting the generation of reactive oxygen metabolites.
- Strategies to enhance endogenous antioxidant capabilities.
- Evaluation in animal models of post-ischaemic reperfusion injury.
Main Results:
- Antioxidant efficacy correlates with the proportion of injury attributable to oxidant mechanisms.
- Promising results observed in preclinical animal models.
- Successful outcomes in early-phase controlled clinical trials.
Conclusions:
- Pharmacological intervention targeting oxidative stress is a viable therapeutic strategy.
- Antioxidant therapies hold significant potential for treating conditions involving tissue injury.
- Further clinical validation supports the use of antioxidants in managing oxidative damage.